Event Details


Overview of Presentations at the 2019 American Epilepsy Society (AES) Annual Meeting

Sunday, December 8, 2019

Webcast Presentation

Title
Overview of Presentations at the 2019 American Epilepsy Society (AES) Annual Meeting

Additional posters shown in the “Genetic Epilepsies – Updates in the Science and Diagnosis” Scientific Exhibit:

Note: Neurocrine Biosciences, Inc. has an exclusive license to XEN901 and other pre-clinical, selective Nav1.6 and dual Nav1.2/1.6 inhibitors. All trademarks are the property of their respective owners.

Date / Time
Sunday, December 8, 2019
Location
Baltimore, MD